• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


71.3600 USD 1.5500 2.22%

As of 16:30:00 ET on 01/26/2015.

Company Profile for Alkermes PLC (ALKS)

Alkermes PLC researches pharmaceuticals. The Company develops treatments for central nervous system disorders such as addiction, schizophrenia and depression, and diabetes.

Contact Information

Alkermes PLC

Phone: 353-9064-95000

Key Executives for Alkermes PLC (ALKS)

Richard F PopsChairman/CEOShane M CookePresident
James M Frates "Jim"Senior VP/CFO/TreasurerGordon G PughSenior VP/COO/Chief Risk Ofcr
Mark StejbachSenior VP/Chief Commercial OfcrKathryn L BibersteinSenior VP/Secy/General Counsel
Michael J Landine "Mike"Senior VP:Corporate DevelopmentElliot W EhrichSenior VP:R&D/Chief Medical Officer
Rebecca J PetersonSenior VP:Corporate Communication

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil